# Safety of Sofosbuvir in People With Advanced Kidney Failure

> **NCT03883698** · PHASE3 · COMPLETED · sponsor: **Sanjay Gandhi Postgraduate Institute of Medical Sciences** · enrollment: 30 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Hepatitis C

## Interventions

- **DRUG:** Sofosbuvir
- **DRUG:** Daclatasvir 60 mg

## Key facts

- **NCT ID:** NCT03883698
- **Lead sponsor:** Sanjay Gandhi Postgraduate Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-15
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883698, "Safety of Sofosbuvir in People With Advanced Kidney Failure". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03883698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*